Nanobiotix S.A. Cash Flows From Used In Operations Before Changes In Working Capital
Nanobiotix S.A. (NNBXF) reported Cash Flows From Used In Operations Before Changes In Working Capital of -EUR 29.82 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital · last filed 2026-03-31
| Period end | Cash Flows From Used In Operations Before Changes In Working Capital 6 month | Cash Flows From Used In Operations Before Changes In Working Capital 12 month |
|---|---|---|
| 2025-12-31 | -29.82M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | -18.87M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | -33.77M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | -17.97M EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | -22.39M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | -22.95M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | -39.40M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | -21.44M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | -41.41M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | -24.67M EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | -33.30M EUR 20-F · filed 2023-04-24 | |
| 2020-06-30 | -15.86M EUR 6-K · filed 2021-09-08 | |
| 2019-12-31 | -39.65M EUR 20-F · filed 2022-04-08 | |
| 2018-12-31 | -27.06M EUR 20-F/A · filed 2021-04-08 |